The first volunteer has received a dose in a first-in-human trial of Oxford's Lassa fever vaccine, a major milestone in ...

A world-first single-dose vaccine against the dengue virus, manufactured and approved for use in Brazil, will especially ...

To accurately gauge a vaccine’s risks, it is also crucial to compare its side effects with the effects of the illness it ...

According to research by SNS Insider, the U.S. Viral Vector Manufacturing Market is projected to grow at a CAGR of 21.26%, driven by rapid expansion in gene therapy development, rising outsourcing to ...

VAERS, the Vaccine Safety Datalink, clinical investigators in the U.S. and their European counterparts detected that these ...

Blog - The Oxford Vaccine Group has vaccinated the first volunteer in a first-in-human trial of a Lassa vaccine The CEPI-funded trial is being conducted in Oxford, with a second phase 1 trial due to ...

A world-first single-dose vaccine against the dengue virus, manufactured and approved for use in Brazil, will especially ...

The "Vaccine Development Companies Landscape: Competitive Landscape, Recent Expansions, Partnerships and Collaborations, Big Pharma Initiatives and Cost Price Analysis" report has been added to ...

Vaccines are among the greatest achievements in medical science, saving millions of lives every year. They protect individuals and entire communities from infectious diseases such as measles, polio, ...

The Food and Drug Administration is seeking to drastically change procedures for testing vaccine safety and approving vaccines, based on unproven ...